Mavacamten

TERMINATED · PHASE3 · Cardiomyopathy, Hypertrophic

Trial terminated because of lack of efficacy in the short term acute phase

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.